Sunday , 18 April 2021
Breaking News
Home » Health » Circulating Tumor Cells (CTC) Technologies
Circulating Tumor Cells (CTC) Technologies

Circulating Tumor Cells (CTC) Technologies announces a report on “Circulating Tumor Cells (CTC) Technologies Market Research Report”. The report serves as a guide to CTC industry, covering more than 190 companies that are engaged in CTC studies/screening, products and services.

This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 190 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to CTC Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, and Asia-Pacific with 29 exclusive graphically represented exhibits.

Report Highlights

Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch’s CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.

Report by Chapter

I. Scope and Methodology:

This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.

II. Report Synopsis:

Synopsis of the report summarizes the global Circulating Tumor Cells (CTC) Technologies market, by Cancer Type and Function Type. The chapter provides global market values (2010 – 2022) in US$. A List of major Global companies is also provided.

III. Market Dynamics:

Market Dynamics chapter provides information on global markets for Circulating Tumor Cells (CTC) Technologies. The chapter includes global market analysis (in US$) by geographic regions (North America, Europe, Asia-Pacific and Rest of World); analysis of each region by both Cancer type and Function type. The section includes key market trends and an industry outlook.

IV. Competitor Dynamics:

The chapter includes brief business profile of (55) major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc.

V. Product/Technology Research:

This chapter gives an insight into Circulating Tumor Cells (CTC) Technologies market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Various CTC detection methods, and the challenges faced by the industry are also discussed. Various research activities in the field of CTC Technologies finds a mention in this chapter.

About aadolfst01

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>